388 articles with AmerisourceBergen
AmerisourceBergen, a global healthcare solutions leader, is expanding access to its Opioid Assistance Pilot Program to all full-time associates and their dependents in Texas, South Carolina, North Carolina, and Pennsylvania who are enrolled in a company-sponsored medical plan.
8/16/2019Biopharma companies strengthen their executive ranks and boards with new additions.
Ms. Donato will focus on operationalizing and evolving a strategic framework for the organization, while identifying and implementing a range of growth initiatives that will add further value for its customers.
AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care.
AmerisourceBergen Corporation reported that in its fiscal year 2019 third quarter ended June 30, 2019, revenue increased 4.9 percent to $45.2 billion.
At ThoughtSpot 2019, Good Neighbor Pharmacy Unveils Tools that Empower Independent Pharmacists to Tell Their Unique Stories
AmerisourceBergen and Good Neighbor Pharmacy unveiled tools to help pharmacies connect with customers in new and meaningful ways.
OneOncology and AmerisourceBergen to Support Community Oncology Practices to Provide High-Quality Cancer Care to Patients Across the Nation
AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter Fiscal 2019 on Thursday, August 1, 2019, prior to the opening of trading on the New York Stock Exchange.
Suite of new offerings uses digital innovation to better identify and evaluate evidence for enhanced strategic planning
AmerisourceBergen Foundation Convenes 50+ Nonprofit Leaders to Share Best Practices for Advancing Healthcare
At inaugural conference, leaders explore new ways to build connections, foster collaboration and create long-term impact
Chronically Simple is a digital health offering designed for patients, by a patient
Patients using AdhereTech Smart Pill Bottles through US Bioservices stayed on therapy longer, refilled prescriptions more frequently
This acquisition will further simplify and streamline the necessary communication of clinical evidence and health economic information between manufacturers and population health decision makers.
AmerisourceBergen Releases Annual Corporate Citizenship Report, Highlights Top Activities Aimed at Creating Healthier Futures in 2018
AmerisourceBergen, a global healthcare solutions leader, released its Corporate Citizenship Report: 2018 Year in Review detailing how the company continues to advance sustainable practices and community investment to create healthier futures around the world.
The Board of Directors of AmerisourceBergen Corporation (NYSE: ABC) declared a quarterly cash dividend of $0.40 per common share, payable June 3, 2019, to stockholders of record at the close of business on May 20, 2019.
Revenues of $43.3 billion for the Second Quarter, a 5.6 Percent Increase Year-Over-Year
Lash Group and Medisafe Form Strategic Collaboration to Advance Patient Adherence by Deploying Mobile Engagement Before the First Fill
Together they will provide an end-to-end patient adherence solution that combines a top-rated mobile platform within Lash Group’s current hub services programs.
US Bioservices Selected by Janssen as Single-Source Specialty Pharmacy Provider for BALVERSA™ (erdafitinib)
US Bioservices, a specialty pharmacy that is a part of AmerisourceBergen, today announced that it has been selected by Janssen Biotech, Inc. (Janssen) to dispense BALVERSA™ (erdafitinib). Janssen received U.S. Food and Drug Administration (FDA) approval for BALVERSA™ on April 12, 2019
AmerisourceBergen Foundation Commemorates National Prescription Drug Take Back Day with Grant to CADCA in Support of Youth-Led Drug Disposal Program
Grant will empower next generation of youth advocates and equip them to make change
DIACOMIT® is approved by the FDA in two formulations – capsules and powder for oral suspension.